Paweł Rostoff

Effects of Polyunsaturated Omega-3 Fatty Acids on Responsiveness to Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention

Grzegorz Gajos, Paweł Rostoff, Anetta Undas et al. · Journal of the American College of Cardiology · 2010 · 120 citations

Thrombosis, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy +11

Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy

Ewa Konduracka, Andrzej Gackowski, Paweł Rostoff et al. · European Heart Journal · 2007 · 80 citations · Full text

Hypertension, Heart Failure, Diastolic Function +18

Reduced Thrombin Formation and Altered Fibrin Clot Properties Induced by Polyunsaturated Omega-3 Fatty Acids on Top of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention (OMEGA-PCI Clot)

Grzegorz Gajos, J Zalewski, Paweł Rostoff et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2011 · 68 citations · Full text

Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective cohort study

Ewa Konduracka, Grażyna Cieślik, Danuta Galicka-Latała et al. · Acta Diabetologica · 2013 · 63 citations · Full text

Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease

Małgorzata Poręba, Paweł Rostoff, Aleksander Siniarski et al. · Cardiovascular Diabetology · 2018 · 53 citations · Full text